Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01120795
What this trial is testing

Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy

Who this might be right for
Chronic Hepatitis C
Melbourne Health 55
Not applicableUnknownNCT02102451
What this trial is testing

Control and Elimination Within Australia of Hepatitis C From People Living With HIV

Who this might be right for
Hepatitis CHIVHIV-HCV Coinfection
Kirby Institute 492
Not applicableStudy completedNCT03546530
What this trial is testing

The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients

Who this might be right for
Hepatitis BInterferon
The First Hospital of Jilin University 228
Testing effectiveness (Phase 2)Study completedNCT01188772
What this trial is testing

Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

Who this might be right for
Hepatitis C Virus
Gilead Sciences 147
Large-scale testing (Phase 3)Study completedNCT00738530
What this trial is testing

Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 649
Early research (Phase 1)Study completedNCT01701336
What this trial is testing

Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients

Who this might be right for
Hepatitis C
ReiThera Srl 9
Post-approval studies (Phase 4)Ended earlyNCT01465919
What this trial is testing

Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C

Who this might be right for
Depression
Seoul National University Boramae Hospital 5
Early research (Phase 1)Study completedNCT01603212
What this trial is testing

Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 6
Not applicableStudy completedNCT00981071
What this trial is testing

The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis Exposure

Who this might be right for
Tuberculosis
Armed Forces Capital Hospital, Republic of Korea 32
Testing effectiveness (Phase 2)Study completedNCT00363649
What this trial is testing

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Post-approval studies (Phase 4)Study completedNCT00917358
What this trial is testing

Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C

Who this might be right for
Hepatitis C
National Taiwan University Hospital 42
Testing effectiveness (Phase 2)Study completedNCT01259817
What this trial is testing

Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

Who this might be right for
High Risk Polycythemia VeraHigh Risk Essential Thrombocythemia
Ronald Hoffman 135
Large-scale testing (Phase 3)Study completedNCT00211692
What this trial is testing

Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial

Who this might be right for
Chronic Hepatitis C
Minneapolis Veterans Affairs Medical Center 64
Testing effectiveness (Phase 2)WithdrawnNCT01714089
What this trial is testing

Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Revalesio Corporation
Testing effectiveness (Phase 2)Study completedNCT00238329
What this trial is testing

PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Barbara Ann Karmanos Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT00525031
What this trial is testing

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 55
Not applicableLooking for participantsNCT06923280
What this trial is testing

Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens

Who this might be right for
Hepatitis B, Chronic
Huashan Hospital 72
Large-scale testing (Phase 3)UnknownNCT00025402
What this trial is testing

Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
III. Medizinische Klinik Mannheim 1,000
Large-scale testing (Phase 3)Study completedNCT01962441
What this trial is testing

SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 601
Large-scale testing (Phase 3)UnknownNCT00002869
What this trial is testing

Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Medical Research Council 800
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation